An Open-Label Extension Study Of Lamotrigine In Subjects With Bipolar Disorder

Mise à jour : Il y a 4 ans
Référence : NCT00360126

Femme et Homme

  • | Pays :
  • Australia
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The precursor study (SCA101469) was an open-label, prospective multicentre study in adult subjects diagnosed with bipolar disorder consisting of 36 weeks treatment with lamotrigine. The current study is to provide 12 months post study access to open-label lamotrigine for participants of the SCA101469 study.


Critère d'inclusion

  • Bipolar disorder

Liens